Treatment outcome on pulmonary tuberculosis and extra pulmonary tuberculosis in government general hospital, ongole

Hafeeza Y; Rishitha M; Naga Yeseswini S; Venu Babu A; Sumavi Sekhar J; Venkat Rao M

doi:10.46795/ijhcbs.v4i1.420

Y.Hafeeza Students, Doctor of Pharmacy, QIS College of Pharmacy, Ongole, Prakasam (Dist.), Andhra Pradesh, India, 523002
M.Rishitha Students, Doctor of Pharmacy, QIS College of Pharmacy, Ongole, Prakasam (Dist.), Andhra Pradesh, India, 523002
S.Naga Yeseswini Students, Doctor of Pharmacy, QIS College of Pharmacy, Ongole, Prakasam (Dist.), Andhra Pradesh, India, 523002
A.Venu Babu Students, Doctor of Pharmacy, QIS College of Pharmacy, Ongole, Prakasam (Dist.), Andhra Pradesh, India, 523002
J.Sumavi Sekhar Assistant Professor, Department of Pharmacy Practice, QIS College of pharmacy, Ongole, Prakasam (Dist.), Andhra Pradesh, India, 523002.
M.Venkat Rao MBBS, M.D, H.O.D & Professor of Pulmonary Medicine, Government General Hospital, Ongole, Prakasam (Dist.), Andhra Pradesh, India, 523002.

DOI https://doi.org/10.46795/ijhcbs.v4i1.420

Abstract

Background: Tuberculosis is a global disease leading to cause death worldwide. The Revised National Tuberculosis Control Programme (RNTCP), Directly Observed Treatment Short Course (DOTS), was launched to reduce tuberculosis mortality, improve patient adherence to treatment, and prevent the development of drug resistance. The aim of this study was treatment outcome of tuberculosis. Treatment outcome is an important indication of tuberculosis control programme.

Methodology: An ambispective observational study was conducted in a government general hospital from August 2019 to January 2020 on the treatment outcomes of PTB and EPTB in the 15 years and older age group, both males and females, on category I regimens. Patients with comorbidities like HIV, diabetes, and social habits like smoking were included. Record based TB diagnosed data (August 2019 to January 2020) are taken and asses their treatment outcome after 6months of complete therapy. The recorded and collected data were analysed to evaluate the success rate of treatment outcomes for PTB and EPTB.

Results: A total of 350 subjects were enrolled in the study, of which 311 are included and 39 are excluded due to incomplete data. The study with age group of 15 and above years where males 218(70.10%) and females 93(29.90%). Total pulmonary tuberculosis cases are 277 (89.07%), and extrapulmonary tuberculosis cases are 34 (10.93%). Subjects with HIV 48(15.43%), Diabetes 54(17.37%) and Tobacco smoking 85(27.33%). The treatment outcome was observed as follows: cured 144 (46.30%), treatment completed 98 (31.51%), transfer out 10 (3.21%), died 27 (8.69%), treatment failure 7 (2.26%), treatment lost to follow-up 14 (4.50%), and treatment regimen changed 11 (3.53%). At the end of the treatment, the success rate was found to be 78%.

Conclusion: This study shows that the TB patients' treatment success rate was 78%, which is slightly less than the RNTCP norms. The died rate was 8% which is higher than national average. Perhaps the services need to improve tuberculosis case detection in HIV patients, while cure rates have to be improved in RNTCP. EPTB case enrolment is very low, whereas the referral system has to improve its services. So that EPTB cases enrolment may increase its number. The early detection may enhance the cure rates in patients.

Keywords: RNTCP, DOTS, TREATMENT, OUTCOME, PTB, EPTB, SUCCESS RATE

Downloads

Download data is not yet available.

References

1. Raviglione MC, Snider DE, and Kochi A.: "Global epidemiology of tuberculosis, morbidity, and mortality of a worldwide epidemiology." Journal of the American Medical Association, 1995, 273:220–6.
2. Shargie EB, Lidtjorn B.Determinants of Treatment Adherence among Smear-PositivePulmonary Tuberculosis Patients in Southern Ethiopia. Apeer-reviewed weekly medical journal covering the full spectrum of the medical sciences 2007, 4(37).
3. RNTCP status report. TB India, Central Tuberculosis Division, New Delhi, 2007, 106, http://www.tbcindia.org.
4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country WHO Global Surveillance and Monitoring Project, 1997, 282:677–686.
5. Pandit S, Dey A, Datta A, Chaudari, Saha M, Sengupta A, Kunda S, Bhuniya S, Sing S. Oct.–Dec. 2009: vol 26/4:109-113. Five years of experience with the Revised National Tuberculosis Control Programme in Northern Kolkatta, India.
6. Chada S.L. and Bhagi R.P. Treatment outcome in tuberculosis patients placed on the Directly Observed Treatment Short Course (DOTS). A Cohort Study, Ind J. Tub 2000; 47-155.
7. Dholkia Y., Damani U., and Desai C. Relapse following Directly Observed Therapy Short Course (DOTS): A Follow-Up Study Ind J. Tub 2000; 47(4):233-236.
8. Treatment Outcome of Tuberculosis Patients in Selected Health Centers in Addis Ababa: A Five-Year Retrospective Study Yonas Alem, Solomon Gebre Selassie2* 1College of Health Sciences, Ambo University, Ambo, Ethiopia Department of Microbiology, Immunology, and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Ethiopia.
9. Treatment Outcome of Tuberculosis Patients in Selected Health Centers in Addis Ababa: A Five-Year Retrospective Study Yonas Alem, Solomon Gebre Selassie, 2* College of Health Sciences, Ambo University, Ambo, Ethiopia; 2 Department of Microbiology, Immunology, and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Ethiopia.
10. Hong Kong Chest Service/British Medical Research Council Controlled trial of 2,4 and 6 months of pyrazinamide in 6 months, three times weekly regimens for smear positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampicin, and pyrazinamide. Results after 30 months Am Rev Respir Dis 1991;143:700-6.
11. Barman P Profile and treatment outcome among pulmonary tuberculosis patients (under the dots) attending a tertiary care centre in Dibrugarh district, Assam. J.Evolution Med. Dent. Sci. 2017;6(41):3246-3250, DOI: 110.14260/Jemds/2017/703.
12. Chandra PV, Rafi SA. A comparative study of the clinical profile and outcome of cases of pulmonary tuberculosis with and without diabetes mellitus under the RNTCP in rural and semi urban areas, Medak district Evolution Med. Dent. Sci. 2017;6(84):5874-5878, DOI:10.14260/Jemds/2017/1276.
13. Vandana Bhoi, Anil Bhoi, Asha Pratinidhi, and Narendra Madhekar " Treatment Outcomes in Patients treated under RNTCP in Karad Tuberculosis Unit". Journal of Evolution of Medical and Dental Sciences 2014; vol.3, Issue 69, December 11, page:14763–14769, DOI: 10.14260/Jemds/2014/3983.
14. Harries A.D. Et al. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi Int J Tuberc Lung 2003;7(11):1040-1044.
15. Choudary S, Tayade B, and Keshwani P Efficacy and treatment outcome of DOTS in RNTCP Pancreas Journal of Medical Sciences 2012;2(1):32-6.
16. Zenebe Y, Adem Y, Mekonnen D, et al. Profile of tuberculosis and its response to Anti-TB drugs among tuberculosis patients treated under the TB control programme at felege-hiwot referral hospital, Ethiopia BMC Public Health 2016;16;688.
17. Karanjekar VD, Lokare PO, Gaikwad AV, et al., "Treatment outcome and follow-up of tuberculosis patients who underwent a directly observed short course of treatment at the rural health training centre in Paithan, Aurangabad, India," Ann Med Health Science Res 2014;4(2):222-6.
18. Chada SL, Bhagi RP. Treatment outcome in tuberculosis patients placed on a directly observed treatment short course (DOTS)—a cohort study. Indian J Tuberc 2000; 47:4(2):222-6.
19. Jemal M, Tarekegne D, Atanaw T, et al. Treatment outcome of tuberculosis patients in Metema Hospital, Northwest Ethiopia: a four-year retrospective study Mycobact Dis 2015; 5:190.
20. Barman P., et al., "Profile and treatment outcome among pulmonary tuberculosispatients under the dots attending a tertiary care centre in Dibrugarh district, Assam,"J.Evolution Med. Dent. Sci. 2017;6(41):3246-3250, DOI: 110.14260/Jemds/2017/703.